HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin Shen Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

4/2022Phase Ia/Ib Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: 
Safety, Efficacy, and Biomarkers.
10/2020The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer.
12/2018MicroRNA-598 inhibits the proliferation and invasion of non-small cell lung cancer cells by directly targeting ZEB2.
6/2017Characterization of Aurora A and Its Impact on the Effect of Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer.
4/2017Safety and effectiveness of localized lung resection combined with neoadjuvant chemotherapy in the treatment of stage I-II non-small cell lung cancer.
1/2011Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lin Shen Research Topics

Disease

193Neoplasms (Cancer)
11/2022 - 05/2003
113Stomach Neoplasms (Stomach Cancer)
04/2022 - 06/2006
56Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 05/2003
28Adenocarcinoma
07/2022 - 12/2011
25Neoplasm Metastasis (Metastasis)
01/2022 - 09/2008
22Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2022 - 11/2004
19Disease Progression
01/2022 - 12/2012
18Esophageal Squamous Cell Carcinoma
10/2022 - 06/2007
17Gastrointestinal Neoplasms (Gastrointestinal Cancer)
05/2022 - 05/2008
17Hypertension (High Blood Pressure)
05/2022 - 06/2008
14Spinal Cord Injuries (Spinal Cord Injury)
05/2022 - 04/2012
13Diarrhea
07/2022 - 12/2007
12Infections
09/2021 - 06/2006
11Carcinoma (Carcinomatosis)
04/2021 - 08/2004
10Breast Neoplasms (Breast Cancer)
06/2022 - 01/2011
9Microsatellite Instability
01/2022 - 01/2020
9Neutropenia
01/2021 - 05/2008
9Inflammation (Inflammations)
12/2020 - 08/2008
8Nasopharyngeal Carcinoma
01/2022 - 04/2015
8Esophageal Neoplasms (Esophageal Cancer)
04/2021 - 03/2012
8Osteoporosis
09/2020 - 09/2004
7Stroke (Strokes)
07/2022 - 01/2017
7Hepatocellular Carcinoma (Hepatoma)
04/2022 - 11/2014
7Disease Resistance
09/2021 - 02/2009
7Postmenopausal Osteoporosis
04/2019 - 08/2007
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 01/2011
6Melanoma (Melanoma, Malignant)
01/2022 - 09/2013
5Glioma (Gliomas)
11/2022 - 11/2015
5Lymphoma (Lymphomas)
08/2022 - 08/2012
5Hypoxia (Hypoxemia)
01/2022 - 10/2014
5Lung Neoplasms (Lung Cancer)
01/2022 - 09/2013
5Fibrosis (Cirrhosis)
09/2021 - 04/2009
5Heart Failure
04/2021 - 05/2002
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2020 - 02/2008
5Body Weight (Weight, Body)
09/2014 - 04/2009
4Reperfusion Injury
01/2022 - 02/2014
4Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022 - 01/2016
4Ischemia
11/2021 - 10/2015
4Circulating Neoplastic Cells
10/2021 - 11/2017
4Fatigue
02/2021 - 06/2007

Drug/Important Bio-Agent (IBA)

44Biomarkers (Surrogate Marker)IBA
08/2022 - 06/2008
28Cisplatin (Platino)FDA LinkGeneric
05/2022 - 05/2003
28Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
27Paclitaxel (Taxol)FDA LinkGeneric
10/2022 - 06/2007
24Pharmaceutical PreparationsIBA
05/2022 - 06/2007
23Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 05/2003
22Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2010
20Trastuzumab (Herceptin)FDA Link
01/2021 - 08/2010
19Imatinib Mesylate (Gleevec)FDA Link
01/2022 - 11/2004
19Capecitabine (Xeloda)FDA Link
01/2021 - 12/2008
18Irinotecan (Camptosar)FDA LinkGeneric
10/2022 - 12/2007
15Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 03/2008
14Biological ProductsIBA
01/2022 - 09/2004
13Cetuximab (Erbitux)FDA Link
05/2022 - 05/2008
11human ERBB2 proteinIBA
04/2022 - 08/2010
10Tyrosine Kinase InhibitorsIBA
05/2022 - 12/2011
10Sunitinib (Sutent)FDA Link
01/2022 - 12/2011
9DNA (Deoxyribonucleic Acid)IBA
06/2022 - 08/2004
9MicroRNAs (MicroRNA)IBA
01/2022 - 03/2012
9RNA (Ribonucleic Acid)IBA
12/2021 - 06/2007
9LigandsIBA
12/2021 - 08/2007
9Leucovorin (Folinic Acid)FDA Link
08/2018 - 05/2003
8Monoclonal AntibodiesIBA
08/2022 - 08/2010
8Indicators and Reagents (Reagents)IBA
09/2021 - 03/2008
7Phosphotransferases (Kinase)IBA
05/2022 - 06/2017
7PlatinumIBA
01/2022 - 11/2013
7HMPL-013IBA
01/2022 - 01/2017
7regorafenibIBA
01/2022 - 01/2020
6ParaffinIBA
11/2022 - 08/2004
6B7-H1 AntigenIBA
10/2022 - 01/2020
6ErbB Receptors (EGF Receptor)IBA
05/2022 - 01/2011
6Therapeutic UsesIBA
01/2022 - 05/2003
6CateninsIBA
01/2020 - 01/2013
5Messenger RNA (mRNA)IBA
01/2022 - 06/2016
5pembrolizumabIBA
04/2021 - 04/2019
5Bevacizumab (Avastin)FDA Link
02/2021 - 10/2011
5Tumor Biomarkers (Tumor Markers)IBA
11/2020 - 01/2015
5Folic Acid (Vitamin M)FDA LinkGeneric
01/2017 - 09/2013
4Docetaxel (Taxotere)FDA Link
10/2022 - 01/2016
4Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 10/2007
4Interleukin-6 (Interleukin 6)IBA
05/2022 - 10/2009
4Doxorubicin (Adriamycin)FDA LinkGeneric
05/2022 - 11/2014
4Alanine Transaminase (SGPT)IBA
05/2022 - 12/2008
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
05/2022 - 01/2020
4surufatinibIBA
02/2022 - 11/2020
4toripalimabIBA
02/2022 - 01/2020
4thiamine triphosphorate (TTP)IBA
01/2022 - 06/2007
4Long Noncoding RNAIBA
01/2022 - 01/2020
4EnzymesIBA
09/2021 - 06/2011
4GemcitabineFDA Link
05/2021 - 08/2007

Therapy/Procedure

105Therapeutics
10/2022 - 05/2002
98Drug Therapy (Chemotherapy)
10/2022 - 06/2007
30Immunotherapy
10/2022 - 01/2016
12Radiotherapy
08/2020 - 06/2007
8Transplantation
01/2022 - 05/2002
8Aftercare (After-Treatment)
01/2020 - 06/2006
6Neoadjuvant Therapy
01/2021 - 06/2012
5Precision Medicine
08/2021 - 02/2012
5Highly Active Antiretroviral Therapy (HAART)
02/2012 - 03/2008
4Combination Drug Therapy (Combination Chemotherapy)
08/2022 - 12/2008